Medical/Pharmaceuticals

EAN Congress 2022: COVID-19 positive patients at higher risk of developing neurodegenerative disorders, new study shows

COVID-19 positive outpatients are at an increased risk of neurodegenerative disorders compared with individuals who tested negative for the virus, a new study presented today at the 8th European Academy of Neurology (EAN) Congress has shown. VIENNA, June 25, 2022 /PRNewswire/ -- The study, which...

2022-06-25 06:01 6971

Stryker's debut at World Intelligence Congress: Bringing Stryker's Advanced Digital Healthcare to China

SHANGHAI, June 24, 2022 /PRNewswire/ -- Stryker (NYSE:SYK), a leading medical technologies company, attended the 6th World Intelligence Congress (WIC) in China, showcasing how its Advanced Digital Healthcare solutions brings clinical, operational and financial values for the healthcare market. Th...

2022-06-24 23:00 6556

Daewoong Pharmaceutical begins multinational phase 2 clinical trial for DWN12088, a new drug for idiopathic pulmonary fibrosis

- U.S. Food and Drug Administration (FDA) approved the IND for the phase 2 clinical trial for patients with idiopathic pulmonary fibrosis - Daewoong Pharmaceutical to start a multinational phase 2 clinical trial for DWN12088 in September SEOUL, South Korea, June 24, 2022 /PRNewswire/ -- Daewoong...

2022-06-24 21:00 4354

WhaleTeq: Widespread as AEDs Are, Have These Life-Saving Machines Really Come in Handy?

TAIPEI, June 24, 2022 /PRNewswire/ -- Unlike most products, AEDs sit idle most of the time. However, a life-or-death situation follows when it's being used. The consequences can be tragic if an AED isn't properly maintained. WhaleTeq, a professional medical device test solution provider proposed ...

2022-06-24 12:00 4635

Novavax COVID-19 Vaccine Nuvaxovid™ Recommended for Expanded Conditional Marketing Authorization in the European Union by CHMP for Adolescents Aged 12 Through 17

* Upon authorization, Nuvaxovid™ would be the first protein-based option for adolescents aged 12 through 17 inEurope * Nuvaxovid™ demonstrated 80% efficacy and was generally well-tolerated in adolescents GAITHERSBURG, Md., June 24, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechn...

2022-06-24 03:24 5529

Use of BioMAP Platform to Assess Nutraceuticals Published in BioMed Central

ST. CHARLES, Mo., June 24, 2022 /PRNewswire/ -- Eurofins Discovery, the leading brand with over 35 years of success providing a complete solution of products and services for drug discovery, announces a client publication advancing cognitive health research through use of the company's BioMAP...

2022-06-24 01:00 2985

MGI Wins Company Innovation of the Year at 2022 Globee® Awards for Advanced COVID-19 Response Efforts

SHENZHEN, China, June 24, 2022 /PRNewswire/ -- MGI, a company committed to being a world-leading life science innovator, has been awarded a Silver Globee® in the 14th Annual 2022 Golden Bridge Business and Innovation Awards® for its innovative COVID-19 pandemic control and response efforts worldw...

2022-06-24 00:17 3883

Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial in Italy

MELBOURNE, Australia and SAN FRANCISCO, June 23, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that the Italian Medicin...

2022-06-23 23:00 3258

Berry Oncology launches HIFI Pan-Cancer Screening, a multi-cancer early screening product for detecting six high-risk cancers at one time

BEIJING, June 23, 2022 /PRNewswire/ -- On June 23, Berry Oncology, a global leading company specialized in genomic testing and early cancer screening, announced the launch of its innovative one-time precision product HIFI Pan-Cancer Screening, which is an early multi-cancer screening product ...

2022-06-23 22:39 3708

Merck Opens €59 Million CDMO Facility to Address Demand for Critical Cancer Therapies

* Expansion doubles production of the most highly potent active pharmaceutical ingredients (HPAPIs) * Merck now one of industry's largest manufacturers of these components globally * Builds on company's 30 years' CDMO experience with multi-step, complex, and highly potent compounds DARMSTAD...

2022-06-23 21:00 5537

I-Mab Receives Top Rankings in Five Categories by Institutional Investor

GAITHERSBURG, Md. and SHANGHAI, June 23, 2022 /PRNewswire/ -- I-Mab ("I-Mab" or the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that it was ranked among the top companies i...

2022-06-23 20:00 2354

Fosun International's FTSE Russell ESG Rating Upgraded and Becomes First-time Constituent of FTSE4Good Index Series

HONG KONG, June 23, 2022 /PRNewswire/ -- The world's leading index company, FTSE Russell, recently announced the latest ESG (Environmental, Social and Governance) rating results of Fosun International Limited (HKEX stock code: 00656) ("Fosun International"). Fosun International's FTSE Russell ESG...

2022-06-23 18:56 5085

SCG Cell Therapy Presents Clinical Proof-of-Concept Data at International Liver Congress (ILC) 2022 Annual Meeting

* Clinical trial interim results of SCG101 shows tumour control with lesion shrinkage observed in two out of three patients with advanced HBV-related HCC * Results show rapid and significant serum HBsAg reduction indicates signal of antiviral activity * Data presented support the advancement...

2022-06-23 17:11 2703

How Can Digitalization of Medical Devices Boost Productivity in Med-tech

The digital transformation of medical devices encourages medtech players to deliver significant value for providers and patients, says Frost & Sullivan. SAN ANTONIO, June 23, 2022 /PRNewswire/ -- The global medical devices industry is undergoing a major transformation in business models, technolo...

2022-06-23 15:12 3819

Ocumension OT-401 (Product name: YUTIO), a treatment for chronic non-infectious uveitis officially approved for marketing by the National Medical Products Administration

BEIJING, June 23, 2022 /PRNewswire/ -- Ocumension Therapeutics (1477.HK)announced that the New Drug Application (NDA) for the core product in its pipeline, OT-401 (Sterile non-bioerodible intravitreal implant, Product  name: YUTIO), was officially approved by the National Pharmaceutical Administ...

2022-06-23 12:19 3416

A Painless, Micro Injection that One Can Do Oneself with the Latest Chula's Innovation "Detachable and Dissolvable Microneedles"

BANGKOK, June 23, 2022 /PRNewswire/ -- A startup under the umbrella of CU Innovation Hub in collaboration with the Chula Faculty of Science has developed an innovative"Detachable and Dissolvable Microneedle" that makes any injections easy and painless for everyone, while also significantly reduci...

2022-06-23 10:00 3523

GSK Malaysia Launches Their #GiveBack Recycling Campaign for Safe Disposal of Old Inhalers

Reducing greenhouse gas emissions and material waste from harming the environment PETALING JAYA, Malaysia, June 23, 2022 /PRNewswire/ -- GSK Malaysia is committed to its long-term ambition of delivering net zero emissions across all operations by 2030. By striving to reduce its environmental imp...

2022-06-23 09:22 4783

China Pharma Announces Receipt of Noncompliance Notice from NYSE American

HAIKOU, China, June 22, 2022 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that onJune 15, 2022, the Company received a letter from NYSE American LLC ("NYSE American" or the "Exchange"...

2022-06-23 05:00 3659

First American Patient Treated with VenusP-Valve™ Under Compassionate Use

HANGZHOU, China, June 22, 2022 /PRNewswire/ -- VenusP-Valve™, an in-house developed novel medical device of Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as "Venus Medtech"), recently completed its first compassionate use atUniversity of Virginia Advanced Cardiac Valve Center in...

2022-06-22 18:02 3431

2022 Tang Prize Laureates--Six Voices that Provide Stability to the World

TAIPEI, June 22, 2022 /PRNewswire/ -- Since the outbreak of COVID-19, more than 530 million inflections have been reported globally. With the virus still raging in many countries, the world is suffering from supply chain disruptions and decade-high inflation, which has been exacerbated by the ris...

2022-06-22 10:30 1175
1 ... 547548549550551552553 ... 644